StemCellAtlasPowered by Stem Plus Clinic · Sofia, EU Get matched with the clinic
☰
Treatments Cell therapies Who we help Costs Cost calculator Data Guides Journal Get matched with the clinic
Home › Treatments › Diabetes (Type 1 & 2) · MSCs from Amniotic Membrane
MSCs from Amniotic Membrane

MSCs from Amniotic Membrane for Diabetes (Type 1 & 2)

How Stem Plus applies MSCs from Amniotic Membrane within a personalised Diabetes (Type 1 & 2) protocol — in the EU, from €3,000–€8,000.

For Diabetes (Type 1 & 2), MSCs from Amniotic Membrane are selected for their specific regenerative profile and delivered under GMP conditions. The protocol combines cell type, dose and delivery route to match your individual assessment.

This is one of several cell options for Diabetes (Type 1 & 2). Compare them on the Diabetes (Type 1 & 2) overview, or see the MSCs from Amniotic Membrane page.

Educational information; investigational for several conditions. Outcomes vary.

Related

Diabetes (Type 1 & 2) overviewMSCs from Amniotic MembraneDiabetes (Type 1 & 2) costCost Explorer

Compare stem-cell therapy by country, cost and evidence — in one place.

StemCellAtlas is your guide to stem-cell therapy: what the evidence shows, which conditions are treated, and the real all-in cost by country — typically €3,000–8,000 with our partner Stem Plus (Sofia), Europe's lowest-cost EU destination, versus $15,000–35,000 in the US.

Get an honest assessment